It's definitely one for the long term patient holder. I believe the market is pricing in far too much risk. Management continues to manage this company exceptionally well. I would expect more MIS buy backs to bolster the company's harvest quantities over the next few years. I hope this is offered to retail investors in greater proportions than this years' raising
It's definitely one for the long term patient holder. I believe...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)